Development and validation of an eating behavior patient‐reported outcome measure in people living with obesity or overweight
Obesity · 2025
DOI: 10.1002/oby.24299 ↗At a glance
Validierungsstudie in Obesity, 2025. Written by Donald M Bushnell and 8 co-authors. Institution: PPD, Evidera, Thermo Fisher Scientific, Wilmington, North Carolina, USA. Major MEDLINE topics: Patient Reported Outcome Measures, Obesity, Feeding Behavior, Overweight. Cited 7 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY 4.0). Funded by: Boehringer Ingelheim.
Abstract (original language)
Objective
The objective of this study was to develop a measure of eating behaviors in adults living with obesity or overweight.
Methods
Based on concept‐elicitation ( n = 53) and cognitive‐debriefing ( n = 15) studies, a draft eating behavior patient‐reported outcome (EB PRO) measure was developed. Its psychometric properties were established using data from a 46‐week clinical trial of an investigational antiobesity medication ( n = 387).
Results
The final EB PRO comprised 12 items across two domains (i.e., “Desire to Eat” and “Capacity to Resist”; 6 items each) and a Total Eating Behavior score (0–48; higher scores worse). The EB PRO demonstrated good test–retest reliability (intraclass correlation coefficients > 0.7). Confirmatory factor analysis showed a comparative fit index of 0.98 with good internal consistency (Cronbach α > 0.7). The EB PRO generally exhibited moderate‐to‐large correlations with the Patient Global Impression of Severity questionnaire and Three‐Factor Eating Questionnaire and weaker correlation with the 36‐Item Short‐Form Health Survey version 2 Physical Functioning scale. All EB PRO scores improved from baseline to week 46 ( p < 0.0001), demonstrating sensitivity to change with therapy. Clinically meaningful thresholds were defined as eight‐ and four‐point changes in Total Eating Behavior and domain scores, respectively.
Conclusions
The EB PRO measure is a promising tool for assessing eating behaviors in people with obesity or overweight.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- PPD, Evidera, Thermo Fisher Scientific, Wilmington, North Carolina, USA.
- The Brod Group, Mill Valley, California, USA.
- Department of Psychology, Institute of Population Health, University of Liverpool, Liverpool, UK.
- St. Vincent's University Hospital and University College Dublin School of Medicine, Dublin, Ireland.
- Private Practice, Toronto, Ontario, Canada.
- Diabetes and Endocrinology Consultants, Morehead City, North Carolina, USA.
ORCID profiles: Donald M Bushnell, Meryl Brod, Carl A Roberts, Carel W Le Roux, Oren Steen, Anastasia Uster
Funding
- Boehringer Ingelheim
Cite
APA
Bushnell, D. M., Fung, S., Brod, M., Roberts, C. A., Le Roux, C. W., Steen, O., Lucas, K. J., Hennige, A. M., & Uster, A. (2025). Development and validation of an eating behavior patient‐reported outcome measure in people living with obesity or overweight. Obesity. https://doi.org/10.1002/oby.24299
Vancouver
Bushnell DM, Fung S, Brod M, Roberts CA, Le Roux CW, Steen O, et al. Development and validation of an eating behavior patient‐reported outcome measure in people living with obesity or overweight. Obesity. 2025. doi:10.1002/oby.24299
BibTeX
@article{Bushnell2025,
author = {Bushnell, Donald M and Fung, Shirley and Brod, Meryl and Roberts, Carl A and Le Roux, Carel W and Steen, Oren and Lucas, Kathryn J and Hennige, Anita M and Uster, Anastasia},
title = {Development and validation of an eating behavior patient‐reported outcome measure in people living with obesity or overweight},
journal = {Obesity},
year = {2025},
doi = {10.1002/oby.24299}
}
EUVIMED